EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the antagonistic secondary metabolites of Paenibacillus polymyxa MEZ6 against Staphylococcus aureus

Na Zhao, Mingjiao Huang, Yang Yang, Ruxia Cai, Jian Peng, Guo Guo

Frontiers in Microbiology · 31.07.2025 · 16

DOI: 10.3389/fmicb.2025.1617807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 31.07.2025. Verfasst von Na Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Key Laboratory of Microbio and Infectious Disease Prevention & Control, School of Basic Medical Sciences, Guizhou Medical University, Guiyang…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Paenibacillus polymyxa is an essential bio-control bacterium capable of producing numerous antagonistic compounds with potential usefulness. Methicillin-resistant Staphylococcus aureus (MRSA) is a significant bacterial strain that infects hospitals and communities, exhibiting considerable antibiotic resistance and posing a substantial threat to human health, thereby becoming a major bio-safety concern worldwide. The purpose of this study was to investigate the antibacterial properties and mechanisms of the secondary metabolites of P. polymyxa (MEZ6) against MRSA.

Methods

This study used microdilution procedures and growth and bactericidal kinetics studies to investigate the effects of MEZ6 metabolites on MRSA, and reverse-phase high-performance liquid chromatography (HPLC) and mass spectrometry (LC/MC) were used to detect the secondary metabolites of MEZ6. Results and discussion The results show that MEZ6 secondary metabolites can inhibit MRSA growth, prevent biofilm formation, reduce the expression of virulence genes ( agrA , spa , and clf-1 ), disrupt cell structure, increase membrane permeability, and lead to the accumulation of ROS. Through systematic characterization, MEZ6 metabolites maybe tryptophan-associated fraction (TAF). This study establishes a systematic theoretical framework for the development and application of bacterial metabolites.

Schlagwörter

Stichwörter der Autor:innen

Paenibacillus polymyxaStaphylococcus aureusmechanismsecondary metabolitestryptophan-associated fraction

Autor:innen und Institutionen

  • Guizhou Key Laboratory of Microbio and Infectious Disease Prevention & Control, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
  • Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.

Zitieren

APA

Zhao, N., Huang, M., Yang, Y., Cai, R., Peng, J., & Guo, G. (2025). Characterization of the antagonistic secondary metabolites of Paenibacillus polymyxa MEZ6 against Staphylococcus aureus. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1617807

Vancouver

Zhao N, Huang M, Yang Y, Cai R, Peng J, Guo G. Characterization of the antagonistic secondary metabolites of Paenibacillus polymyxa MEZ6 against Staphylococcus aureus. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1617807

BibTeX
@article{Zhao2025,
  author = {Zhao, Na and Huang, Mingjiao and Yang, Yang and Cai, Ruxia and Peng, Jian and Guo, Guo},
  title = {Characterization of the antagonistic secondary metabolites of Paenibacillus polymyxa MEZ6 against Staphylococcus aureus},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1617807}
}
Kostenlos starten →